A scoring system to guide the decision for a new systemic treatment after at least two lines of palliative chemotherapy for metastatic cancers: a prospective study-Reference-Cited by-同舟云学术

A scoring system to guide the decision for a new systemic treatment after at least two lines of palliative chemotherapy for metastatic cancers: a prospective study

Published:2017-03-28 Issue:9 Volume:25 Page:2715-2722
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Chanez Brice,Bertucci François,Gilabert Marine,Madroszyk Anne,Rousseau Frédérique,Perrot Delphine,Viens Patrice,Raoul Jean-Luc

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/article/10.1007/s00520-017-3680-1/fulltext.html

Reference29 articles.

1. Schnipper LE, Smith TJ, Raghavan D et al (2012) American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol 30:1715–1724. doi: 10.1200/JCO.2012.42.8375

2. Silvestri G, Pritchard R, Welch HG (1998) Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ 317:771–775. doi: 10.1136/bmj.317.7161.771

3. Slevin ML, Stubbs L, Plant HJ et al (1990) Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ 300:1458–1460

4. Weeks JC, Catalano PJ, Cronin A et al (2012) Patients’ expectations about effects of chemotherapy for advanced cancer. N Engl J Med 367:1616–1625. doi: 10.1056/NEJMoa1204410

5. The AM, Hak T, Koëter G, van Der Wal G (2000) Collusion in doctor-patient communication about imminent death: an ethnographic study. BMJ 321:1376–1381

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Helical tomotherapy for asymptomatic chemotherapy-refractory or -unfit multiple (3 or more) metastases;Reports of Practical Oncology and Radiotherapy;2022-03-14

2. Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population: Results from the Dutch Castration-resistant Prostate Cancer Registry;European Urology Focus;2021-07

3. What Goals Do Patients and Oncologists Have When Starting Medical Treatment for Metastatic Lung Cancer?;Clinical Lung Cancer;2021-05

4. Patients with Metastatic Lung Cancer and Oncologists’ Views on Achievement of Treatment Goals and Making the Right Treatment Decision: A Prospective Multicenter Study;Medical Decision Making;2021-03-30